FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 83 filers reported holding FLEXION THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 2.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $8,424,000 | +93.3% | 675,000 | +75.3% | 0.04% | +63.6% |
| Q4 2018 | $4,358,000 | -39.5% | 385,000 | 0.0% | 0.02% | -26.7% |
| Q3 2018 | $7,203,000 | +23.1% | 385,000 | +70.1% | 0.03% | +15.4% |
| Q2 2018 | $5,850,000 | +48.1% | 226,300 | +28.4% | 0.03% | +44.4% |
| Q1 2018 | $3,951,000 | -30.3% | 176,300 | -22.1% | 0.02% | -30.8% |
| Q4 2017 | $5,667,000 | +11.9% | 226,300 | +8.0% | 0.03% | +8.3% |
| Q3 2017 | $5,066,000 | +19.6% | 209,500 | 0.0% | 0.02% | +9.1% |
| Q2 2017 | $4,236,000 | +49.4% | 209,500 | +98.8% | 0.02% | +46.7% |
| Q1 2017 | $2,836,000 | +101.6% | 105,400 | +42.4% | 0.02% | +87.5% |
| Q4 2016 | $1,407,000 | +89.4% | 74,000 | +94.7% | 0.01% | +100.0% |
| Q3 2016 | $743,000 | +83.9% | 38,000 | +40.7% | 0.00% | +100.0% |
| Q2 2016 | $404,000 | – | 27,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,500,000 | $36,270,000 | 4.72% |
| Gagnon Advisors, LLC | 108,498 | $2,623,000 | 1.99% |
| NEXTHERA CAPITAL LP | 271,136 | $6,556,000 | 1.69% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 883,321 | $21,359,000 | 1.39% |
| GILDER GAGNON HOWE & CO LLC | 3,961,647 | $95,793,000 | 1.35% |
| GAGNON SECURITIES LLC | 144,331 | $3,490,000 | 1.30% |
| MILLER VALUE PARTNERS, LLC | 1,181,325 | $28,564,000 | 1.23% |
| SCHOLTZ & COMPANY, LLC | 55,250 | $1,336,000 | 1.05% |
| ARDSLEY ADVISORY PARTNERS LP | 175,000 | $4,232,000 | 0.56% |
| Ratan Capital Management LP | 32,077 | $776,000 | 0.47% |